3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
70
OTHER
32
UNKNOWN
1
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
2
Head and Neck Neoplasms
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma
1
Interventions
S 1 (combination)
11
titanium silicide
5
Oxaliplatin
5
Cisplatin
3
nimotuzumab
2
Surgical Procedures, Operative
2
Docetaxel
2
toripalimab
1
raltitrexed
1
pembrolizumab
1
Trastuzumab
1
Taxes
1
Radiotherapy, Intensity-Modulated
1
Paclitaxel
1
Irinotecan
1
Injections
1
Chemotherapy, Adjuvant
1
Capecitabine
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
Stomach Neoplasms
×
pembrolizumab
×
Clear all
NCT02346955
2020-08-27
MK-6018-001
KitovPharma
Phase 1
Terminated
27 enrolled